Myocardin and Stat3 act synergistically to inhibit cardiomyocyte apoptosis

Area of Science:

• Cardiovascular Biology
• Molecular Cell Biology
• Transcriptional Regulation

Background:

• Signal transducer and activator of transcription 3 (Stat3) and Myocardin are key regulators of cardiomyocyte functions, including differentiation, proliferation, and apoptosis.
• Understanding the precise roles of these proteins in cardiomyocyte apoptosis is crucial for developing strategies for myocardial protection.

Purpose of the Study:

• To elucidate the novel anti-apoptotic functions of Myocardin and Stat3 in cardiomyocytes.
• To investigate the molecular mechanisms by which Myocardin and Stat3 regulate cardiomyocyte apoptosis.

Main Methods:

• Utilized neonatal rat cardiomyocytes to study apoptosis.
• Assessed gene expression of apoptosis-related proteins (Bcl-2, Bax, Apaf-1, caspase-9, caspase-3, Mcl-1).
• Investigated the role of the CArG box in Myocardin/Stat3-mediated transcriptional activation.

Main Results:

• Myocardin and Stat3 demonstrated significant anti-apoptotic effects.
• These proteins increased the expression of anti-apoptotic Bcl-2 and Mcl-1.
• They concurrently reduced the expression of pro-apoptotic genes: Bax, Apaf-1, caspase-9, and caspase-3.
• Myocardin/Stat3-mediated transcriptional activation of Bcl-2 and Mcl-1 was dependent on the CArG box.
• Synergistic inhibition of staurosporine-induced apoptosis was observed.

Conclusions:

• A novel Myocardin/Stat3 signaling pathway with anti-apoptotic functions in cardiomyocytes was identified.
• This pathway involves the upregulation of Bcl-2 and Mcl-1 expression via the CArG box.
• The findings provide a molecular basis for Myocardin/Stat3's role in myocardial protection by inhibiting cardiomyocyte apoptosis.